Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;22(4):445-449.
doi: 10.1634/theoncologist.2016-0270. Epub 2017 Feb 20.

Using Metaphors to Explain Molecular Testing to Cancer Patients

Affiliations

Using Metaphors to Explain Molecular Testing to Cancer Patients

Ana P M Pinheiro et al. Oncologist. 2017 Apr.

Abstract

Background: Molecular testing to identify targetable molecular alterations is routine practice for several types of cancer. Explaining the underlying molecular concepts can be difficult, and metaphors historically have been used in medicine to provide a common language between physicians and patients. Although previous studies have highlighted the use and effectiveness of metaphors to help explain germline genetic concepts to the general public, this study is the first to describe the use of metaphors to explain molecular testing to cancer patients in the clinical setting.

Methods: Oncologist-patient conversations about molecular testing were recorded, transcribed verbatim, and coded. If a metaphor was used, patients were asked to explain it and assess its helpfulness.

Results: Sixty-six patients participated. Nine oncologists used metaphors to describe molecular testing; 25 of 66 (38%) participants heard a metaphor, 13 of 25 (52%) were questioned, 11 of 13 (85%) demonstrated understanding and reported the metaphor as being useful. Seventeen metaphors (bus driver, boss, switch, battery, circuit, broken light switch, gas pedal, key turning off an engine, key opening a lock, food for growth, satellite and antenna, interstate, alternate circuit, traffic jam, blueprint, room names, Florida citrus) were used to explain eight molecular testing terms (driver mutations, targeted therapy, hormones, receptors, resistance, exon specificity, genes, and cancer signatures).

Conclusion: Because metaphors have proven to be a useful communication tool in other settings, these 17 metaphors may be useful for oncologists to adapt to their own setting to explain molecular testing terms. The Oncologist 2017;22:445-449Implications for Practice: This article provides a snapshot of 17 metaphors that proved useful in describing 8 complicated molecular testing terms at 3 sites. As complex tumor sequencing becomes standard of care in clinics and widely used in clinical research, the use of metaphors may prove a useful communication tool, as it has in other settings. Although this study had a small sample, almost all of the patients who were exposed to metaphors in explaining molecular testing reported it as being helpful to their understanding. These 17 metaphors are examples of potentially useful communication tools that oncologists can adapt to their own practice.

Keywords: Communication; Comprehension; Metaphor; Molecular sequencing; Physician‐patient relationship.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Similar articles

Cited by

References

    1. Blanchette PS, Spreafico A, Miller FA et al. Genomic testing in cancer: Patient knowledge, attitudes, and expectations. Cancer 2014;120:3066–3073. - PubMed
    1. Lea DH, Kaphingst KA, Bowen D et al. Communicating genetic and genomic information: Health literacy and numeracy considerations. Public Health Genom 2011;14:279–289. - PMC - PubMed
    1. Brown RF, Butow P, Butt DG, Moore A, Tattersall MH. Developing ethical strategies to assist oncologist in seeking informed consent to cancer clinical trials. Soc Sci Med 2004;58:379–390. - PubMed
    1. Albrecht TL, Ruckdeschel JC, Riddle JC et al. Communication and decision making about cancer clinical trials. Patient Educ Counsel 2003;50:39–42. - PubMed
    1. Fallowfield L, Jenkins V, Farewell V et al. Efficacy of a cancer research UK communication skills training model for oncologists: A randomised controlled trial. Lancet 2002;359:650–656. - PubMed

Publication types